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Background: Cofilin is a member of the actin depolymerizing factor (ADF)/cofilin family, which regulates actin
dynamics. Increasing evidence suggests that mitochondrial translocation of cofilin appears necessary for the
regulation of apoptosis.
Results: We report that allyl isothiocyanate (AITC) potently induces mitochondria injury and apoptosis. These events
were accompanied by a loss of polymerized filamentous actin (F-actin) and increase in unpolymerized globular
actin (G-actin). AITC also induces dephosphorylation of cofilin through activation of PP1 and PP2A. Only
dephosphorylated cofilin binds to G-actin and translocates to mitochondria during AITC-mediated apoptosis.
Mechanistic study revealed that interruption of ROCK1/PTEN/PI3K signaling pathway plays a critical role in
AITC-mediated dephosphorylation and mitochondrial translocation of cofilin and apoptosis. Our in vivo study
also showed that AITC-mediated inhibition of tumor growth of mouse leukemia xenograft model is in association
with dephosphorylation of cofilin.
Conclusions: These findings support a model in which induction of apoptosis by AITC stems primarily from
activation of ROCK1 and PTEN, and inactivation of PI3K, leading in turn to activation of PP1 and PP2A, resulting in
dephosphorylation of cofilin, which binds to G-actin and translocates to mitochondria, culminating in the
dysfunction of mitochondria, release of cytochrome c and apoptosis.
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Mitochondria are the major organelles involved in the bio-
chemical execution of apoptosis [1]. Apoptotic proteins
that target mitochondria may increase the permeability of
the mitochondrial membrane and cause apoptotic effec-
tors to leak out [2]. Cytochrome c is released from mito-
chondria into the cytoplasm and in turn activates/cleaves
caspase-9 by forming a complex with apoptotic protease
activating factor-1 (Apaf-1), leading to activating the ef-
fector caspase-3 [3]. Although the role of mitochondria in
controlling downstream apoptotic events such as caspases
activation is relatively well characterized, mechanisms by* Correspondence: gaoning59@gmail.com
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reproduction in any medium, provided the orwhich upstream apoptotic signals are transduced to mito-
chondria remain largely elusive.
Actin cytoskeleton is involved in diverse cellular func-
tions, including cell growth, motility, differentiation, as
well as apoptosis [4]. Alteration of actin dynamics might
be responsible for modulating apoptosis [5]. Recent data
suggests that the activity of actin regulatory protein such
as ADF/cofilin plays a critical role in the regulation of
apoptosis in mammalian cells [6]. However, normal
apoptosis in cofilin-1-deficient mouse fibroblasts argue
against a general role of cofilin-1 in apoptosis progres-
sion [7]. Cofilin is a member of ADF/cofilin family,
which regulates actin dynamics by increasing the rate of
actin depolymerization and facilitating actin filament
turnover [8]. It was recently shown that cofilin trans-
location to mitochondria appears necessary for thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pore and subsequent release of cytochrome c and the
initiation of apoptosis [9]. Phosphorylation of cofilin at a
single serine residue, Ser3, is a common mechanism
regulating its activity [10]. Only dephosphorylated cofilin
is involved in its mitochondrial translocation. In con-
trast, phosphorylation of cofilin at Ser 3 suppressed its
mitochondrial translocation [9]. Phosphorylation/de-
phosphorylation of cofilin at Ser 3 is modulated by mul-
tiple regulatory kinases and phosphatases. Cofilin is
phosphorylated at Ser3 by the LIM kinase LIMK and
TES kinase TESK and is dephosphorylated by phospha-
tases such as slingshot, chronophin and PP1/PP2A
[11-15]. Each of these phosphatases is regulated by dif-
ferent upstream signaling pathways such as PI3K [15].
Allyl isothiocyanate (AITC) is a naturally occurring
compound that exhibits anticancer activity. Many com-
monly consumed cruciferous vegetables are rich sources
of AITC [16]. Evidence supports that AITC exerts its
antiproliferative effects through inducing cell cycle arrest
and apoptosis in various cancer cell lines in vitro and in
several tumor xenograft models in vivo [17]. For instance,
AITC induces cell cycle arrest at G2/M phase and apop-
tosis in human bladder cancer cells and inhibits tumor
growth of bladder cancer cell xenograft via JNK activation
and Bcl-2 phosphorylation [18,19]. AITC induces G2/M
cell cycle arrest and apoptosis in human breast cancer
cells via ROS production and ERK signaling pathway [20].
AITC also induces apoptosis in human leukemia cells
through cleavage of Bid and activation of JNK [21]. Recent
studies suggest that a mitochondria-dependent pathway
may play important roles in AITC-mediated apoptosis
[18,20,22]. However, the molecular mechanism by which
AITC regulates the mitochondrial pathway of apoptosis in
human leukemia cells has not yet been explored.
In the present study, we provide evidence for the first
time that AITC induces dephosphorylation of cofilin, which
binds to G-actin and translocates to mitochondria, leading
in turn to modifying the functional dynamics of actin cyto-
skeleton, resulting in the dysfunction of mitochondria, re-
lease of cytochrome c and apoptosis. Dephosphorylation of
cofilin can be achieved with phosphatases PP1 and PP2A,
which are regulated by ROCK1/PTEN/PI3K signaling path-
way. Our in vivo results indicate that dephosphorylation of
cofilin may contribute to AITC-mediated inhibitory effects
on tumor growth of U937 xenograft mouse model. These
findings provide a novel mechanistic basis for AITC as a
leukemia treatment strategy.
Results
AITC potently induces mitochondrial injury and apoptosis
in transformed and primary human leukemia cells
Flow cytometry analysis revealed that exposure of cells
to 5 μM AITC for 24 h resulted in a moderate increasein mitochondrial injury (loss of △ψm) and apoptosis
(Figure 1A). These events became apparent at 10 μM
and very extensive at 20 μM concentrations. A time-
course study of cells exposed to 20 μM AITC revealed a
moderate increase in mitochondrial injury and apoptosis
as early as 6 h after drug exposure. These events became
apparent after 9 and 12 h of drug exposure and very ex-
tensive after 24 h of drug exposure (Figure 1A). Consist-
ent with these findings, the same AITC concentrations
and exposure intervals caused cleavage/activation of
caspase-9 and caspase-3, and degradation of PARP.
These events were also accompanied by release of cyto-
chrome c into the cytosolic fraction (Figure 1B).
To determine whether these events were restricted to
myeloid leukemia cells, parallel studies were performed
in Jurkat and HL-60 leukemia cells. These cells exhibited
apoptotic effects of AITC similar to those observed in
U937 cells (Figure 1C). Also, Jurkat and HL-60 cells
exhibited comparable degrees of caspase-9 and -3 activa-
tion and PARP degradation, and cytochrome c release
(Figure 1D).
To determine whether AITC could also trigger apop-
tosis in primary human leukemia cells, primary leukemia
cells isolated from 17 AML patients were treated with-
out or with 20 μM AITC for 24 h, after which apoptosis
was determined by Annexin V/PI analysis. Exposure of
these AML blasts to AITC resulted in marked increase
in apoptosis (Figure 1E). Consistent with these findings,
treatment of leukemia blasts from 2 AML patients with
AITC also resulted in cleavage/activation of caspase-9
and -3, degradation of PARP, and release of cytochrome
c (Figure 1F). In contrast, AITC exerted little toxicity to-
ward normal CD34+ bone marrow cells (Figure 1G).
Taken together, these findings suggest that AITC select-
ively induces mitochondrial injury and apoptosis in
transformed and primary human leukemia cells but not
in normal hematopoietic cells.Alteration of G/F-actin ratio and actin dynamics in
response to AITC
G/F-actin ratio is an indicator of the extent of actin dy-
namics and might be responsible for regulating apoptosis
[5]. To understand the mechanism of AITC-mediated
apoptosis through affecting actin dynamics, we separated
actin into G and F fractions and evaluated their relative
content. Exposure of cells to AITC resulted in decrease in
the polymerized F-actin and increase in the unpolymerized
G-actin (Figure 2A). Consistent with these findings, con-
focal microscopy showed that treating with AITC for
different time intervals resulted in decrease in levels of
F-actin and increase in levels of G-actin (Figure 2B). Such
findings suggest that AITC induces actin dynamics
through filamentous actin depolymerization.
Figure 1 AITC selectively induces apoptosis and mitochondrial injury in transformed and primary human leukemia cells. U937 cells
were treated without or with various concentrations of AITC for 24 h, or treated with 20 μM AITC for different time intervals as indicated.
(A) Apoptosis and reduction in △ψm were determined using flow cytometry as described in Methods. ‘Low’ △ψm values are expressed as the
percentage of cells exhibiting a diminished mitochondrial membrane potential. Error bars represent means ± SD for (n=3). (B) Total cellular
extracts and cytosolic fractions (C) were prepared and subjected to Western blot analysis using antibodies against PARP, cleaved-caspase 3
(C-Caspase 3), cleaved-caspase 9 (C-Caspase 9) , cytochrome c (Cyto c) and GADPH to ensure equivalent loading. Two additional studies yielded
equivalent results. (C-D) U937, Jurkat, and HL-60 cells were treated without or with 20 μM AITC for 24 h, flow cytometry was used to determine
apoptosis, and Western blot assay was used to determine the expression of PARP, C-Caspase 3, C-Caspase 9, and Cyto c. Error bars represent
means ± SD (n=3). ** P< 0.01 compared with control. (E) Primary leukemia blasts were isolated from the peripheral blood of 17 patients with
AML as described in Methods. After exposure to 20 μM AITC for 24 h, apoptosis was determined using flow cytometry. Error bars represent
means ± SD (n=3). (F) Whole cell lysates and cytosolic fractions (C) in blasts from 2 AML patients were obtained and subjected to Western blot
analysis. (G) Normal CD34+ cells were exposed to 20 μM AITC for 24 h, after which apoptosis was determined using flow cytometry. Error bars
represent means ± SD (n=3). P = 0.056.
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apoptosis is essential for its mitochondrial translocation
Since actin dynamics is regulated by actin depoly-
merization factor cofilin [23], next we examined the levels
of cofilin and actin either in mitochondrial and cytosolic
fractions or total cellular extracts using Western blot ana-
lysis. Treating cells with AITC resulted in marked increase
in levels of cofilin and actin in mitochondrial fraction and
decrease in levels of cofilin and actin in cytosolic fraction
in dose- and time-dependent manners (Figure 2C). In con-
trast, AITC treatment had little or no effect on theexpression of cofilin and actin in total cellular extract. On
the other hand, translocation of cofilin from cytosol to
mitochondria after AITC exposure were also observed in
Jurkat and HL-60 cells, but not in normal CD34+ bone
marrow cells (Additional file 1: Figure S1 A-B). These
findings indicate that mitochondrial translocation of
cofilin may occur through increased of actin with mito-
chondria during AITC-mediated apoptosis.
We then investigated whether the phosphorylation sta-
tus of cofilin can influence its ability to translocate to
mitochondria and induce apoptosis. Phosphorylated
Figure 2 AITC induces shift in G/F-actin, translocation/localization in mitochondria and dephosphorylation of cofilin. (A) U937 cells were
treated with 20 μM AITC for different time intervals as indicated, the levels of F-actin and G-actin were measured using the G-actin/F-actin In Vivo
Assay Kit as described in Methods. Densitometric analysis of the blots were performed by using Quantity One software (Bio-Rad laboratories,
Munchen, Germany) and G/F-actin ratio was calculated. (B) Levels of F-actin (green) and G-actin (red) in cells treated with AITC were imaged by
confocal microscopy. Scale bar represents 5 μm. (C) U937 cells were treated without or with various concentrations of AITC for 24 h, or treated
with 20 μM AITC for different time intervals as indicated. Cell lysates, mitochondrial and cytosolic fractions were prepared and subjected to
Western blot analysis using antibodies against phospho-cofilin (p-cofilin), cofilin and actin. Blots were subsequently stripped and reprobed with
antibody against GADPH and COX IV (mitochondrial fraction) to ensure equivalent loading. (D) U937 cells were pretreated with the caspase
inhibitor Z-VAD-FMK (20 μM) for 2 h, followed by treatment with 20 μM AITC for 24 h. Cell lysates, mitochondrial and cytosolic fractions were
prepared and subjected to Western blot analysis. (E-F) Cells were untreated (control) or treated with 20 μM AITC for 12 h, cofilin was labeled by
an anti-cofilin antibody followed by Alexa 488-conjugated goat anti-mouse antibody (green); fluorescent deoxyribonuclease I conjugates (red) for
staining G-actin; Fluorescent phallotoxins for staining F-actin; mitochondria were stained by Mitotracker Red or Green as described in Methods.
Fluorescence images were collected at similar focal planes by confocal microscopy. Scale bar represents 5 μm. (G) Cell lysates, cytosolic and
mitochondrial fractions of control and AITC-treated cells were prepared and subjected to immunoprecipitation using an anti-cofilin antibody,
followed by immunoblotting analysis.
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cellular extract of control cells. When cells were treated
with AITC, cofilin was dephosphorylated in both the
cytosolic fraction and total cellular extract in dose- and
time-dependent manners (Figure 2C). However, phos-
phorylated cofilin was not identified in mitochondrial
fraction of control and AITC-treated cells.
We also investigated the effects of caspase inhibition by
Z-VAD-FMK on dephosphorylation and mitochondrialtranslocation of cofilin mediated by AITC. Dephosphory-
lation and mitochondrial translocation of cofilin caused by
AITC were not blocked by the caspase inhibitor Z-VAD-
FMK (Figure 2D), suggesting that dephosphorylation and
mitochondrial translocation of cofilin is a common
phenomenon that occurs before caspase activation.
Since dephosphorylated cofilin binds actin with high
affinity, whereas the phosphorylated forms cannot inter-
act [24]. We then investigated whether the association
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volved in AITC-mediated apoptosis using immunofluor-
escence microscopy. The results showed that cofilin and
G-actin were co-localized in cells treated with AITC
(Figure 2E). Because the above results showed that
treating cells with AITC resulted in marked increase in
levels of cofilin and actin in mitochondrial fraction, we
then investigate sub-cellular localization of cofilin during
AITC induces apoptosis by immunofluorescence micros-
copy with the mitochondrion selective probe Mitotracker
Red CMXRos and cofilin. In control cells, total cofilin
levels in mitochondria were not observed. However, when
cells were treated with AITC, cofilin signal was localized
in the mitochondria (Figure 2F). We also investigated
whether actin was localized in mitochondria by immuno-
fluorescence microscopy with the mitochondrion selective
probe Mitotracker Green FM/MitoTracker Red CMXRos
and G-actin/F-actin. Surprisingly, localization of G-actin
but not F-actin in mitochondria was observed after AITC
exposure (Figure 2F).
We further investigated whether AITC affects the asso-
ciation between cofilin and actin in cell lysates, cytosolic
and mitochondrial fractions. Immunoprecipitation of cell
lysates and cytosolic fraction with an anti-cofilin antibody
revealed that actin co-precipitated with cofilin in cell ly-
sates and cytosolic fraction of control cells. However, thisFigure 3 AITC induces dephosphorylation of cofilin by PP1 and PP2A
AITC for 24 h, or treated with 20 μM AITC for different time intervals as ind
blot analysis using antibodies against PP1, PP2A and slingshot (SSH). Cells w
followed by treating with 20 μM AITC for 24 h. (B) Total cellular extracts w
against PP1, PP2A, p-cofilin, and cofilin. (C) Cell lysates were prepared and
associated PP1, PP2A, SSH, and cofilin were determined using immunoblot
flow cytometry. Error bars represent means ± SD (n=3). ** P < 0.01. (E) Tot
to Western blot analysis using antibodies as indicated.actin-cofilin complex was lost after AITC exposure
(Figure 2G). Interestingly, the actin-cofilin complex was
observed in mitochondrial fraction after AITC exposure
(Figure 2G). Taken together, these findings indicate that
AITC dephosphorylates cofilin, which binds with G-actin,
leading to translocation to mitochondria, culminating in
cytochrome c release and apoptosis.
Dephosphorylation of cofilin by PP1 and PP2A is required
for AITC-induced apoptosis
Since cofilin is activated/dephosphorylated by phospho-
atase enzymes such as PPases (PP1 and PP2A) and sling-
shot [24], we examined whether AITC induces the
expression of these phosphatases. Treating cells with
AITC resulted in marked increase in levels of PP1 and
PP2A in dose- and time-dependent manners, whereas
the expression of slingshot was not altered by AITC
(Figure 3A). These events also occurred in Jurkat and
HL-60 cells, but not in normal CD34+ bone marrow
cells (Additional file 1: Figure S1 A-B). To investigate
the role of PP1 and PP2A in AITC mediated dephos-
phorylation of cofilin, a PP1/PP2A inhibitor, calyculin,
was employed. Co-treatment of cells with calyculin sig-
nificantly abrogated AITC-mediated dephosphorylation
of cofilin and expression of PP1 and PP2A (Figure 3B).
To further confirm that PP1 and PP2A are responsible. (A) U937 cells were treated without or with various concentrations of
icated. Total cellular extracts were prepared and subjected to Western
ere pretreated with 50 nM calyculin, a PP1/PP2A inhibitor, for 2 h,
ere prepared and subjected to Western blot analysis using antibodies
subjected to immunoprecipitation using anti-cofilin antibody. The
ting. (D) Cell apoptosis was determined by Annexin V/PI staining and
al cellular extracts and cytosolic fractions were prepared and subjected
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used immunoprecipitaion assays with an anti-cofilin
antibody. Immunoprecipitation of cofilin pulled down
PP1 and PP2A after AITC exposure, whereas slingshot
was not detected (Figure 3C). Inhibition of PP1 and
PP2A by calyculin also blocked the PP1/PP2A–cofilin
interactions (Figure 3C). We further studied whether in-
hibition of PP1 and PP2A is sufficient to prevent cells
from the effects of AITC on apoptosis. Co-treatment of
cells with calyculin markedly abrogated AITC-induced
apoptosis, caspases activation, PARP degradation and
cytochrome c release (Figure 3D and E). Together, our
data reveal that dephosphorylation of cofilin is caused
mainly by induction of PP1 and PP2A phosphatase activ-
ities, which are responsible for AITC-induced apoptosis
in leukemia cells.
Inhibition of PI3K activity is responsible for AITC-induced
PP1 and PP2A activation and cofilin dephosphorylation
and translocation to mitochondria
It has recently shown that phosphatase PP2A activity is
regulated negatively by PI3K signaling [25]. To investigate
whether PI3K plays a role in AITC-induced cofilinFigure 4 Inhibition of PI3K activity contributes to AITC-induced activa
(A) U937 cells were treated without or with various concentrations of AITC
indicated. Total cellular extracts were prepared and subjected to Western b
phospho-Akt [p-Akt (Ser473)], and Akt. Cells were pretreated with 20 μM LY
5 μM AITC for 24 h. (B) Total cellular extracts, cytosolic and mitochondrial f
lysates were prepared and subjected to immunoprecipitation using anti-PI3
immunoblotting. (D) Apoptosis was determined by flow cytometry. Error b
and cytosolic fractions were prepared and subjected to Western blot analydephosphorylation and mitochondrial translocation and
PP1 and PP2A activation, we first examined the effects of
AITC on PI3K activity and its substrate, Akt phosphoryl-
ation. Exposure of cells to AITC resulted in decrease in
levels of phospho-PI3K and phospho-Akt (Ser473) in
dose- and time-dependent manners (Figure 4A). These
events also occurred in Jurkat and HL-60 cells, but not in
normal CD34+ bone marrow cells (Additional file 1:
Figure S1 A-B).
We used specific PI3K inhibitor LY294002 to examine
the effects of inhibition of PI3K activity on dephosphory-
lation and mitochondrial translocation of cofilin and
activation of PP1 and PP2A induced by AITC.
Co-administration of AITC and LY294002 resulted in the
virtual abrogation of Akt activation. Pretreatment with
LY294002 also significantly enhanced AITC-mediated de-
phosphorylation and mitochondrial translocation of cofilin
and activation of PP1 and PP2A (Figure 4B). To further elu-
cidate the mechanism of PP1 and PP2A regulation by PI3K,
we examined the binding of PP1 or PP2A and PI3K using
immunoprecipitation analysis. Our results revealed the sig-
nificant decrease in the association between PP1 or PP2A
and PI3K after AITC exposure (Figure 4C). Pretreatmenttion of PP1/PP2A and mitochondrial translocation of cofilin.
for 24 h, or treated with 20 μM AITC for different time intervals as
lot analysis using antibodies against phospho-PI3K (p-PI3K), PI3K,
294002, a specific PI3K inhibitor, for 2 h, followed by treating with
ractions were prepared and subjected to Western blot analysis. (C) Cell
K antibody. The associated PP1 and PP2A were determined using
ars represent means ± SD (n=3). **P < 0.01. (E) Total cellular extracts
sis using antibodies as indicated.
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association between PP1 or PP2A and PI3K mediated by
AITC (Figure 4C). We further studied whether inhibition
of PI3K activity by LY294002 may enhance AITC-
induced apoptosis. Co-treatment with LY294002 sig-
nificantly promoted AITC-induced apoptosis, caspases
activation, PARP degradation and cytochrome c release
(Figure 4D and E). Together, these findings suggest that
inactivation of PI3K plays a critical role in AITC-induced
cofilin dephosphorylation and mitochondrial translocation
and apoptosis through activation of PP1 and PP2A.
ROCK1/PTEN signaling pathway is involved in AITC-
mediated PI3K inactivation, cofilin dephosphorylation and
mitochondrial translocation, and apoptosis
It has been shown that PTEN is a PI3K upstream nega-
tive regulator and is regulated by ROCK1 [26]. Next we
examined the effects of AITC on the expression of
ROCK1 and PTEN. Treating cells with AITC resulted
in marked decrease in levels of ROCK1 and increase in
cleavage of ROCK1, and increase in levels of PTEN in
dose- and time-dependent manners (Figure 5A). TheseFigure 5 ROCK1/PTEN/PI3K signaling pathway regulates AITC-mediate
and apoptosis. (A) U937 cells were treated without or with various conce
intervals as indicated. Total cellular extracts were prepared and subjected t
represents cleavage fragment. Cells were pretreated with 20 μM Y27632, a
24 h. (B) Total cellular extracts, cytosolic and mitochondrial fractions were p
prepared and subjected to immunoprecipitation using anti-ROCK1 antibod
Apoptosis was determined by Annexin V/PI staining and flow cytometry. E
extracts and cytosolic fractions were prepared and subjected to Western bevents also occurred in Jurkat and HL-60 cells, but not
in normal CD34+ bone marrow cells (Additional file 1:
Figure S1 A-B). To determine the functional significance
of ROCK1 in regulation of PTEN activity and down-
stream molecules during AITC-induced apoptosis, we
then examined the effects of inhibition of ROCK1 by
Y27632 on the expression of ROCK1, PTEN, phospho-
Akt, and phospho-cofilin. Co-administration of Y27632
significantly blocked AITC-mediated ROCK1 activation,
PTEN activity, Akt inactivation and cofilin dephosphory-
lation. Furthermore, Co-administration of Y27632 sig-
nificantly blocked AITC-mediated cofilin translocation
to mitochondria (Figure 5B). To further elucidate the
mechanism of PTEN regulation by ROCK1, we examined
the binding of PTEN and ROCK1 in response to AITC
treatment in leukemia cells. Our results revealed the sig-
nificant increase in the association between PTEN and
ROCK1 after AITC exposure (Figure 5C). Pretreatment
with Y27632 markedly abrogated the association between
PTEN and ROCK1 mediated by AITC (Figure 5C). We
further studied whether inhibition of ROCK1 is sufficient
to prevent cells from the effects of AITC on apoptosis.d dephosphorylation and mitochondrial translocation of cofilin
ntrations of AITC for 24 h, or treated with 20 μM AITC for different time
o Western blot analysis using antibodies against ROCK1 and PTEN. CF
ROCK1 inhibitor, for 2 h, followed by treating with 20 μM AITC for
repared and subjected to Western blot analysis. (C) Cell lysates were
y. The associated PTEN was determined using immunoblotting. (D)
rror bars represent means ± SD (n=3). **P < 0.01. (E) Total cellular
lot analysis using antibodies as indicated.
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AITC-induced apoptosis, activation of caspases-3 and -9,
degradation of PARP and cytochrome c release (Figure 5D
and E). Taken together, these results demonstrate that
ROCK1 plays a significant role in regulating the activation
of PTEN in response to AITC treatment in leukemia cells,
which probably contributes to dephosphorylation and
mitochondrial translocation of cofilin and induction of
apoptosis.Figure 6 AITC inhibits tumor growth and induces apoptosis in U937 x
cells (2 × 106 cells/mouse, s.c.) and randomly divided into two groups (20/
week) or with vehicle control solvent as described in Methods. Tumor grow
as V = (L × W2) × 0.5, where L is the length and W is the width of a xenog
vehicle-treated group (P < 0.01). (B) Gross appearance of two mice with so
Average tumor volume in vehicle control mice and mice treated with 50 m
compared with vehicle control. (D) Body weight changes of mice during th
showed no significant differences between AITC treatment and vehicle con
were sectioned and subjected to H&E staining, TUNEL assay, and immunoh
expression of C-Caspase-3 and p-cofilin.AITC inhibits tumor growth of U937 xenograft model
accompanied by striking induction of apoptosis and
dephosphorylation of cofilin
The ability of AITC in killing both transformed and pri-
mary human leukemia cells in vitro led us to evaluate its
antileukemic activity in vivo. Nude mice were inoculated
subcutaneously with U937 cells, after which mice were re-
ceived injections with vehicle or AITC (50 mg/kg, i.p.) for
6 weeks starting five days after the injection of U937enografts animal model. 40 nude mice were inoculated with U937
group) for treatment with AITC (50 mg/kg, i.p., daily, five times per
th was measured once a week, and tumor volume (V) was calculated
raft. (A) Comparison of animal survival of AITC-treated group and
lid tumor of vehicle control group and AITC-treatment group. (C)
g/kg AITC. Error bars represent means ± SD. *P < 0.05 or **P < 0.01
e six weeks of study. Statistical analysis of body weight changes
trol groups. (E) After treatment with AITC (50 mg/kg), tumor tissues
istochemistry for evaluating histological morphology, apoptosis and
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significant increase in the median survival compared with
untreated controls (52 vs 32 days, P< 0.01) (Figure 6A).
Only the subcutaneous inoculation of U937 cells into
nude mice resulted in a tumor formation at the site of in-
jection in all mice (Figure 6B). Treatment with AITC
resulted in a modest but significant suppression of tumor
growth 2 weeks following drug exposure (**P < 0.01 vs ve-
hicle control). These events became more apparent 3
weeks and 4 weeks and very extensive 5 weeks and 6
weeks after drug exposure (**P < 0.01 vs vehicle control)
(Figure 6B and C). However, no significant changes in
weight or other signs of potential toxicity such as agita-
tion, impaired movement and posture, indigestion or diar-
rhea, and areas of redness or swelling were observed
during the treatment with AITC (Figure 6D).
We then examined the morphological changes and in-
duction of apoptosis in tumor section of U937 xenografts
using H&E staining, TUNEL and immunohistochemistry
analysis. The sections of U937 xenografts from mice
treated with AITC exhibited a reduced number of cancer
cells, with signs of necrosis with infiltration of inflamma-
tory cells and fibrosis (Figure 6E, top panels). Exposure to
AITC resulted in a striking induction of apoptosis in
tumor cells, with signs of numerous dark brown colored
apoptotic cells (Figure 6E, second panels). In addition,
treatment with AITC caused a rapid increase in immu-
noreactivity for cleaved caspase-3, indicative of apop-
tosis (Figure 6E, third pannels). Finally, we applied
immunohistochemistry analysis to evaluate whether
AITC induces dephosphorylation of cofilin in vivo.
Treatment with AITC resulted in markedly decrease in
expression of phospho-cofilin in tissue sections of
tumors (Figure 6E, bottom pannels). However, AITC
had no effect on total cofilin levels in tissue sections of
tumors (data not shown). Such findings suggest that
AITC-mediated antileukemic activity in vivo is associ-
ated with dephosphorylation of cofilin.
Discussion
Actin cytoskeleton plays an important role in diverse cellu-
lar functions, including cell growth and apoptosis [4]. Re-
cent research has highlighted a role of actin cytoskeleton in
the initiation or inhibition of apoptotic processes. Apoptosis
can be triggered by jasplakinolide in Jurkat T cells through
the stabilization of F-actin and these events are accompan-
ied by an increase in caspase-3 activation [27]. Apoptosis
can also be triggered by the destabilization of F-actin
structures. For example, treatment with cytochalasin D
resulted in rapid cytochrome c release from mitochondria,
caspase activation and apoptosis in murine cell lines [28].
Our present results indicate that AITC-induced apoptosis
is probably resulted from actin cytoskeletal rearrange-
ment, because both immunofluorescence staining andimmunoblotting showed a dramatic decrease of polymer-
ized F-actin and a concomitant increase of unpolymerized
G-actin in AITC-treated cells. Since a dynamic switch
between monomeric G-actin and F-actin may be involved
in apoptotic processes, the suppression of actin poly-
merization by AITC might contribute to its effects on
apoptosis.
Cofilin is a member of ADF/cofilin family, which regu-
lates actin dynamics by increasing the rate of actin
depolymerization [8]. It has been shown that mitochon-
drial translocation of cofilin was found to induce apoptosis
in neutrophils [28]. Cofilin was found to translocate to
mitochondria after staurosporine-induced apoptosis in a
neuroblastoma cell [9]. These results suggest that the
actin-binding activity of cofilin is crucial for its apoptosis-
inducing activity. As dephosphorylated cofilin binds to
actin and translocates to mitochondria, actin cytoskeletal
changes may affect mitochondria function, resulting in the
release of cytochrome c and apoptosis [9]. Rehklau, et al
reported that translocation of cofilin to mitochondria is
highly dependent on actin that also translocates to mito-
chondria during apoptosis [7]. These results suggest that
the mitochondrial translocation of actin during apoptosis
is essential for the mitochondrial association with cofilin.
However, the molecular mechanism by which actin trans-
locates to mitochondria and binds with cofilin remains
elusive. Consistent with these studies, our results indicate
that stimulation of apoptosis with AITC resulted in mito-
chondrial translocation of both cofilin and actin. Interest-
ingly, only G-actin but not F-actin was translocated to
mitochondria during AITC-induced apoptosis through the
association with cofilin, based on the following findings:
(i) The co-localization of cofilin and G-actin was observed
in cells treated with AITC; (ii) Cofilin was co-localized
with the mitochondrial marker Mitotracker Red CMXRos,
and G-actin was aslo co-localized with the mitochondrial
marker Mitotracker Green FM; (iii) The association of
cofilin and G-actin was observed in mitochondrial fraction
during AITC-induced apoptosis. To the best of our know-
ledge, this is the first report that the association and mito-
chondrial translocation of cofilin and G-actin are required
for AITC-mediated cell death.
It has been shown that only dephosphorylated cofilin
translocates to mitochondria during apoptosis, whereas
phosphorylation of cofilin suppressed mitochondrial trans-
location [7,9]. Dephosphorylation of cofilin occurs in re-
sponse to many stimuli that activate cells in processes
requiring changes in actin dynamics [29]. As dephosphor-
ylation of cofilin can be regulated by phosphatases such as
slingshot and PPases including PP1 and PP2A [12,13], ac-
tivation of these phosphatases may be required for trans-
location of cofilin to mitochondria during apoptosis. Our
experiments showed that only dephosphorylated cofilin
accumulated in mitochondria after induction of apoptosis
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slingshot, were involved in dephosphorylation of cofilin in-
duced by AITC. Inhibition of PP1 and PP2A with
calyculin, a phosphatase inhibitor, which prevented AITC-
induced dephosphorylation of cofilin and protected cells
from AITC-mediated cell death. PP1 and PP2A are two
major serine/threonine phosphatases, which dephosphory-
late a large number of targets including components of
the actin cytoskeleton [30]. Their recruitment for cofilin
dephosphorylation may be crucial for the actin-binding
activity and mitochondiral traslocation of cofilin. This in
turn indicates the necessity for actin cytoskeletal changes,
resulting in the dysfunction of mitochondria, release of
cytochrome c and apoptosis.
Numerous studies showed that the activity of PPases
are regulated by different upstream signaling pathways
[11]. For example, PI3K negatively regulates PP2A activ-
ity that has significant consequences on receptor func-
tion with broad implications in cellular signaling [25].
Our findings demonstrate that inactivation of PI3K may
contributed AITC-mediated activation of PP1 and PP2A
and dephosphorylation and mitochondrial translocation
of cofilin, based on the following evidence: (i) AITC
inhibited PI3K activity and Akt activation in dose- and
time-dependent manners; (ii) Pretreatment with PI3K
inhibitor LY294002 not only enhanced AITC-inhibited
Akt activation but also enhanced AITC-induced activa-
tion of PP1 and PP2A and dephosphorylation and mito-
chondrial translocation of cofilin; (iii) Pretreatment with
LY294002 enhanced AITC-mediated cell death. It has
been well documented that PTEN is a negative regulator
of PI3K/Akt pathway, which has important roles in a di-
verse range of biological processes, including cell death
and survival [31]. Recent evidence revealed that PTEN is
a newly identified ROCK substrate, which is involved in
the regulation of cell death and survival [26]. A number
of evidence indicates that RhoA/ROCK1 activation en-
hances PTEN activity and suppresses Akt activation. For
instance, PTEN mediates the reduction of Akt phos-
phorylation induced by ROCK activation in HEK cells
[32]. RhoA and its effector kinase ROCK inhibit PI3K
activity by enhancing the activity of PTEN, which nega-
tively regulates PI3K/Akt signaling pathway [33]. Con-
sistence with these reports, our findings suggest that
activation of ROCK1 and PTEN and inactivation of
PI3K could contribute to AITC-induced activation of
PP1 and PP2A and dephosphorylation and mitochon-
drial translocation of cofilin, leading to apoptosis. Specif-
ically, AITC exposure resulted in activation of ROCK1
and PTEN, and inactivation of PI3K/Akt. Inhibition of
ROCK1 activity by Y27632 attenuated AITC-mediated
apoptosis through preventing PTEN activity, Akt inacti-
vation, cofilin dephosphorylation and mitochondrial
translocation.Conclusions
Our data indicate that AITC effectively induces apop-
tosis and mitochondrial injury in transformed and pri-
mary human leukemia cells and U937 tumor xenografts.
Collectively, these findings suggest a hierarchy of events
in AITC-induced apoptosis in which ROCK1 activation
represents the primary insult, leading in turn to PTEN
activation and PI3K inactivation, resulting in PP1 and
PP2A activation, forming dephosphorylated cofilin,
which binds to G-actin and translocates to mitochon-
dria, culminating in dysfunction of mitochondria, release
of cytochrome c and apoptosis (Figure 7). Further efforts
to understand the mechanism(s) by which AITC induces
apoptosis in human leukemia cells in vitro and in vivo




AITC was purchased from Sigma (St Louis, MO). Y-
27632 was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). LY294002 and Z-VAD-FMK pur-
chased from EMD Biosciences (La Jolla, CA). Antibodies
against Akt, cytochrome c, cofilin, actin, PP1, PTEN and
GAPDH were from Santa Cruz Biotechnology (Santa
Cruz, CA); cleaved caspase-3, cleaved caspase-9,
phospho-Akt (Ser473), phosphor-Cofilin (Ser3), PI3K,
phospho-PI3K and Cox IV were from Cell Signaling
Technology (Beverly, MA); ROCK1 and SSH were
from Abcam (Burlingame, CA); PP2A was from BD
Bioscience (San Jose, CA); PARP was from Biomol
(Plymouth Meeting, PA).
Cell culture
U937, HL-60, and Jurkat cells were obtained from the
American Type Culture Collection (Manassas, VA) and cul-
tured in RPMI 1640 medium supplemented with 10% fetal
bovine serum (FBS) and antibiotics. Cells were cultured at
37°C in a humidified atmosphere and 5% CO2 in air.
After approval by the Southwest Hospital Institutional
Review Board (Chongqing, China), peripheral-blood
samples were obtained from 17 patients with newly diag-
nosed or recurrent acute myeloid leukemia (AML) after
acquiring informed consent. AML blasts were isolated
by density gradient centrifugation over Histopaque-1077
(Sigma-Aldrich Co., St Louis, MO) at 600 g for 15
minutes. Isolated mononuclear cells were counted, re-
suspended in RPMI 1640 medium at 8×105/mL for treat-
ment. CD34+ cells from bone marrow mononuclear cells
of healthy donors were isolated using the MACS cell iso-
lation kit (Miltenyi Biotec, BG, German) according to
the manufacturer’s instructions. After washing and enu-
merating as described for mononuclear cells, cells were
suspended at 8×105/mL prior to treatment.
Figure 7 A proposed model for AITC-mediated mitochondrial injury and apoptosis. AITC-induced cell death in which ROCK1 activation
represents the primary insult, leading in turn to PTEN activation and PI3K inactivation, resulting in PP1 and PP2A activation, and
dephosphorylation of cofilin, which binds to G-actin and translocates to mitochondria, and culminating in cytochrome c release, caspases
activation and apoptosis.
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assay
Cells were harvested and apoptosis was analyzed by
flow cytometry using the Annexin V/PI staining kit
(PharMingen, San Diego, CA) according to the manufac-
turer’s instructions. Briefly, 1×106 cells were washed
twice with phosphate-buffered saline (PBS), and stained
with 5 μl of Annexin V-FITC and 10 μl of PI (5 μg/mL) in
1× binding buffer (10 mM HEPES, pH 7.4, 140 mM
NaOH, 2.5 mM CaCl2) for 15 min at room temperature
in the dark. The apoptotic cells were determined using a
Becton-Dickinson FACScan cytoflurometer (Mansfield,
MA, USA). Both early apoptotic (Annexin V-positive, PI-
negative) and late (Annexin V-positive and PI-positive)
apoptotic cells were included in cell death determinations.
A diminished mitochondrial membrane potential
(△ψm) was monitored using DiOC6. For each condition,
4 × 105 cells were incubated in 1 mL 40 nM DiOC6 at
37°C in for 15 minutes and subsequently analyzed using
a Becton Dickinson FACScan cytofluorometer with exci-
tation and emission settings of 488 and 525 nm,
respectively.
Preparation of mitochondrial and cytosolic fractions
Mitochondrial and cytosolic fractions were obtained as
previously described [34]. Briefly, cell pellets were
washed twice with PBS and resuspended in 5 × buffer A
(20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mMEDTA, 1 mM EGTA, 1 mM Na3VO4, 2 mM leupeptin, 1
mM PMSF, 1mM DTT, 2 mM pepstatin, and 250 mM
sucrose). Cells were homogenized by passing them
through a 22-gauge needle 25 times. The homogenate
was centrifuged in three sequential steps: 1000 g, 10,000 g,
and 100,000 g. The 10,000 g pellet was consid-
ered the “mitochondrial” fraction, and the 100,000 g
supernatant the “cytosolic” fraction. These fractions
were subjected to Western blot and immunoprecipita-
tion analyses.
G-actin/F-actin assay
G-actin/F-actin assay were performed by using G-actin /
F-actin In Vivo Assay Kit (Cytoskeleton, Denver, CO)
according to the manufacturer’s instructions. Briefly,
cells were lysed with LAS2 buffer (containing lysis,
F-actin stabilization buffer, ATP stock solution and pro-
tease inhibitor cocktail stock solution) at 37°C for 1 h.
Unbroken cells were removed by centrifugation at 2,000
rpm for 5 min. Cell lysates were then centrifuged at
100,000 g for 1 h, finally F-actin in the pellet and G-
actin in the supernatant. Samples were mix with 5×SDS
sample buffer and then analyzed by western blot with
antibody against actin.
Western blot and immunoprecipitation analysis
Cells were lysed in 1× NuPAGE LDS sample buffer
supplemented with 50 mM dithiothreitol. The proteins
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lose membranes, and processed for immunoblotting as
previously described [35]. For immunoprecipitation ana-
lysis, Cells were lysed in 1% NP-40 buffer (50 mM Tris
(pH 7.4), 150 mM NaCl, 1% Nonidet P-40, 10% glycerol,
1 mM PMSF, 10 μg/mL aprotinin, 10 μg/mL leupeptin,
1 mM Na3VO4). Equal quantities of proteins were incu-
bated with primary antibodies at 4°C on a rocking plat-
form. Immune complexes were collected with protein G
agarose beads (Pierce Biotechnology, Rockford, IL)
followed by several washes in lysis buffer, samples were
boiled and then subjected to SDS-PAGE/Western blot.Immunofluorescence
Cells were collected by centrifugation, resuspend gently
in pre-warmed (37°C) staining solution containing 200
nM MitoTracker Red CMXRos (Molecular Probes, Eu-
gene, OR) for 1 h at 37°C, and washed twice with RPMI
1640 medium. After fixed with 3.7% of methanol-free
formaldehyde for 15 min, and permeabilized with 0.1%
Triton X-100 for 10 min. Slides were blocked with 1%
BSA in PBS for 30 min, then incubated with anti-cofilin
primary antibody at 4°C overnight, followed by the sec-
ondary Alexa 488-conjugated goat anti-mouse antibody
(Molecular Probes, Eugene, OR) for 1 h at room
temperature. Cells were incubated with 50 nM
MitoTracker Green FM (Molecular Probes, Eugene, OR)
after fixation because it can not retained well after fix-
ation. Fluorescent staining of globular and filamentous
actin was performed using Fluorescent Deoxyribonucle-
ase I Conjugates and Fluorescent phallotoxins (Molecu-
lar Probes, Eugene, OR), respectively, according to the
manufacturer's instructions. Images were collected and
analysed using Leica scanning confocal microscope (TCS
SP2 AOB; Wetzlar, Germany).Xenograft assay
Animal studies were conducted according to protocols ap-
proved by Third Military Medical University Institutional
Animal Care and Use Committee. Nude mice (5 weeks old)
were purchased from Vital River Laboratories (VRL,
Beijing, China), and inoculated subcutaneously with 2×106
U937 cells into the lower back of each mouse. Mice were
randomized into two groups (n=20). Five days after tumor
inoculation, Mice were received AITC (50 mg/kg, i.p., five
times per week) or an equal volume of vehicle. Tumor size
and body weight were monitored per week after treatment,
and the survival time of mice was recorded. Tumor tissues
from representative mice were fixed in paraformaldehyde,
embedded in paraffin, sectioned and processed for
hematoxylin and eosin (H&E), terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling assay
(TUNEL) and immunohistochemical analysis.TUNEL, histological and immunohistochemical assay
TUNEL assay were performed by using an In Situ Cell
Death Detection kit (Roche, Mannheim, Germany)
according to the manufacturer’s instructions. Histo-
logical and immunohistochemical assay were performed
as previously described [36].
Statistical analysis
All of the data are expressed as mean ± SD of three indi-
vidual experiments. Group measurements were com-
pared using a Student’s t-test or analysis of variance
(ANOVA). Survival analysis was performed with the
Kaplan–Meier method, and significance was calculated
using the log-rank test. *P < 0.05 or **P < 0.01 were con-
sidered significant.
Additional file
Additional file 1: Figure S1. AITC selectively induces apoptosis in a
variety of leukemia cell lines through ROCK1/PTEN/PI3K-PP1/PP2A-cofilin
pathway. (A) U937, Jurkat, and HL-60 cells were treated without or with
20 μM AITC for 24 h, Cell lysates, mitochondrial and cytosolic fractions
were prepared and subjected to Western blot analysis. (B) Normal
CD34+ cells were treated without or with 20 μM AITC for 24 h, Cell
lysates, mitochondrial and cytosolic fractions were prepared and
subjected to Western blot analysis.
Abbreviations
ADF: Actin depolymerizing factor; AITC: Allyl isothiocyanate; AML: Acute
myeloid leukemia; Apaf-1: Apoptotic protease activating factor-1; F-
actin: Filamentous actin; G-actin: Globular actin; H&E: Hematoxylin and eosin;
TUNEL: Erminal deoxynucleotidyl transferase-mediated dUTP nick end
labeling.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NG and GL designed the experiments; GL, LL, TZ, CS, QC and JZ performed
experiments; NG, GL, EL and PL analyzed data and wrote the paper. All
authors read and approved the final manuscript.
Acknowledgements
This work was supported by Chongqing Natural Science Foundation
(cstc2013jjB10007) and National Natural Science Foundation of China
(No. 30971288).
Author details
1Department of Pharmacognosy, College of Pharmacy, 3rd Military Medical
University, Chongqing 400038, China. 2State Key Laboratory of Natural
Medicines (China Pharmaceutical University), Nanjing 210009, China.
Received: 1 June 2013 Accepted: 17 July 2013
Published: 29 July 2013
References
1. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev
2001, 15:2922–2933.
2. Green DR, Kroemer G: The pathophysiology of mitochondrial cell death.
Science 2004, 305:626–629.
3. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang
X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9
complex initiates an apoptotic protease cascade. Cell 1997, 91:479–489.
4. Gourlay CW, Ayscough KR: The actin cytoskeleton: a key regulator of
apoptosis and ageing? Nat Rev Mol Cell Biol 2005, 6:583–589.
Li et al. Cell Communication and Signaling 2013, 11:50 Page 13 of 13
http://www.biosignaling.com/content/11/1/505. Celeste Morley S, Sun GP, Bierer BE: Inhibition of actin polymerization
enhances commitment to and execution of apoptosis induced by
withdrawal of trophic support. J Cell Biochem 2003, 88:1066–1076.
6. Bamburg JR, Bernstein BW: Roles of ADF/cofilin in actin polymerization
and beyond. F1000 Biol Rep 2010, 2:62.
7. Rehklau K, Gurniak CB, Conrad M, Friauf E, Ott M, Rust MB: ADF/cofilin
proteins translocate to mitochondria during apoptosis but are not
generally required for cell death signaling. Cell Death Differ 2012,
19:958–967.
8. Chen H, Bernstein BW, Bamburg JR: Regulating actin-filament dynamics
in vivo. Trends Biochem Sci 2000, 25:19–23.
9. Chua BT, Volbracht C, Tan KO, Li R, Yu VC, Li P: Mitochondrial translocation
of cofilin is an early step in apoptosis induction. Nat Cell Biol 2003,
5:1083–1089.
10. DesMarais V, Ghosh M, Eddy R, Condeelis J: Cofilin takes the lead. J Cell Sci
2005, 118:19–26.
11. Van Troys M, Huyck L, Leyman S, Dhaese S, Vandekerkhove J, Ampe C: Ins and
outs of ADF/cofilin activity and regulation. Eur J Cell Biol 2008, 87:649–667.
12. Niwa R, Nagata-Ohashi K, Takeichi M, Mizuno K, Uemura T: Control of actin
reorganization by Slingshot, a family of phosphatases that
dephosphorylate ADF/cofilin. Cell 2002, 108:233–246.
13. Ambach A, Saunus J, Konstandin M, Wesselborg S, Meuer SC, Samstag Y:
The serine phosphatases PP1 and PP2A associate with and activate the
actin-binding protein cofilin in human T lymphocytes. Eur J Immunol
2000, 30:3422–3431.
14. Gohla A, Birkenfeld J, Bokoch GM: Chronophin, a novel HAD-type serine
protein phosphatase, regulates cofilin-dependent actin dynamics. Nat
Cell Biol 2005, 7:21–29.
15. Nishita M, Wang Y, Tomizawa C, Suzuki A, Niwa R, Uemura T, Mizuno K:
Phosphoinositide 3-kinase-mediated activation of cofilin phosphatase
Slingshot and its role for insulin-induced membrane protrusion. J Biol
Chem 2004, 279:7193–7198.
16. Conaway CC, Yang YM, Chung FL: Isothiocyanates as cancer
chemopreventive agents: their biological activities and metabolism in
rodents and humans. Curr Drug Metab 2002, 3:233–255.
17. Zhang Y: Allyl isothiocyanate as a cancer chemopreventive
phytochemical. Mol Nutr Food Res 2010, 54:127–135.
18. Geng F, Tang L, Li Y, Yang L, Choi KS, Kazim AL, Zhang Y: Allyl
isothiocyanate arrests cancer cells in mitosis, and mitotic arrest in turn
leads to apoptosis via Bcl-2 protein phosphorylation. J Biol Chem 2011,
286:32259–32267.
19. Bhattacharya A, Tang L, Li Y, Geng F, Paonessa JD, Chen SC, Wong MK,
Zhang Y: Inhibition of bladder cancer development by allyl
isothiocyanate. Carcinogenesis 2010, 31:281–286.
20. Tsai SC, Huang WW, Huang WC, Lu CC, Chiang JH, Peng SF, Chung JG, Lin
YH, Hsu YM, Amagaya S, Yang JS: ERK-modulated intrinsic signaling and G
(2)/M phase arrest contribute to the induction of apoptotic death by
allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells.
Int J Oncol 2012, 41:2065–2072.
21. Xu K, Thornalley PJ: Signal transduction activated by the cancer
chemopreventive isothiocyanates: cleavage of BID protein, tyrosine
phosphorylation and activation of JNK. Br J Cancer 2001, 84:670–673.
22. Chen NG, Chen KT, Lu CC, Lan YH, Lai CH, Chung YT, Yang JS, Lin YC: Allyl
isothiocyanate triggers G2/M phase arrest and apoptosis in human brain
malignant glioma GBM 8401 cells through a mitochondria-dependent
pathway. Oncol Rep 2010, 24:449–455.
23. Winder SJ, Ayscough KR: Actin-binding proteins. J Cell Sci 2005, 118:651–654.
24. Bamburg JR, Wiggan OP: ADF/cofilin and actin dynamics in disease.
Trends Cell Biol 2002, 12:598–605.
25. Vasudevan NT, Mohan ML, Gupta MK, Hussain AK, Naga Prasad SV:
Inhibition of protein phosphatase 2A activity by PI3Kgamma regulates
beta-adrenergic receptor function. Mol Cell 2011, 41:636–648.
26. Li Z, Dong X, Wang Z, Liu W, Deng N, Ding Y, Tang L, Hla T, Zeng R, Li L, Wu D:
Regulation of PTEN by Rho small GTPases. Nat Cell Biol 2005, 7:399–404.
27. Odaka C, Sanders ML, Crews P: Jasplakinolide induces apoptosis in various
transformed cell lines by a caspase-3-like protease-dependent pathway.
Clin Diagn Lab Immunol 2000, 7:947–952.
28. Klamt F, Zdanov S, Levine RL, Pariser A, Zhang Y, Zhang B, Yu LR, Veenstra
TD, Shacter E: Oxidant-induced apoptosis is mediated by oxidation of the
actin-regulatory protein cofilin. Nat Cell Biol 2009, 11:1241–1246.29. Bamburg JR: Proteins of the ADF/cofilin family: essential regulators of
actin dynamics. Annu Rev Cell Dev Biol 1999, 15:185–230.
30. Eichhorn PJ, Creyghton MP, Bernards R: Protein phosphatase 2A
regulatory subunits and cancer. Biochim Biophys Acta 2009, 1795:1–15.
31. Di Cristofano A, Pandolfi PP: The multiple roles of PTEN in tumor
suppression. Cell 2000, 100:387–390.
32. Chang J, Xie M, Shah VR, Schneider MD, Entman ML, Wei L, Schwartz RJ:
Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by
caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis.
Proc Natl Acad Sci USA 2006, 103:14495–14500.
33. Papakonstanti EA, Ridley AJ, Vanhaesebroeck B: The p110delta isoform of PI
3-kinase negatively controls RhoA and PTEN. EMBO J 2007, 26:3050–3061.
34. Gao N, Kramer L, Rahmani M, Dent P, Grant S: The three-substituted
indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-
meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills
human leukemia cells via down-regulation of Mcl-1 through a
transcriptional mechanism. Mol Pharmacol 2006, 70:645–655.
35. Zhou T, Li G, Cao B, Liu L, Cheng Q, Kong H, Shan C, Huang X, Chen J, Gao
N: Downregulation of Mcl-1 through inhibition of translation contributes
to benzyl isothiocyanate-induced cell cycle arrest and apoptosis in
human leukemia cells. Cell Death Dis 2013, 4:e515.
36. Li G, Zhou T, Liu L, Chen J, Zhao Z, Peng Y, Li P, Gao N: Ezrin
dephosphorylation/downregulation contributes to ursolic acid-mediated
cell death in human leukemia cells. Blood Cancer J 2013, 3:e108.
doi:10.1186/1478-811X-11-50
Cite this article as: Li et al.: Mitochondrial translocation of cofilin is
required for allyl isothiocyanate-mediated cell death via ROCK1/PTEN/
PI3K signaling pathway. Cell Communication and Signaling 2013 11:50.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
